SARS-CoV-2 and COVID-19: The most important research questions
2020 · Cell & Bioscience · 751 citations
https://doi.org/10.1186/s13578-020-00404-4
C
Chi‐Ping Chan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
4.5K
Citations
28
h-index
34
i10-index
Chi‐Ping Chan is an academic researcher from University of Hong Kong. The author has contributed to research in topics: interferon and immune responses & Viral Infections and Vectors & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 28, co-authored 45 publications.
ORCID: 0000-0001-6876-0864Papers by this author
worksCytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations
2022 · RNA · 29 citations
https://doi.org/10.1261/rna.079016.121
β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H
2016 · Scientific Reports · 23 citations
https://doi.org/10.1038/srep23938
Suppression of gluconeogenic gene transcription by SIK1-induced ubiquitination and degradation of CRTC1
2018 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 10 citations
https://doi.org/10.1016/j.bbagrm.2018.01.021
FACI is a novel clathrin adaptor protein 2-binding protein that facilitates low-density lipoprotein endocytosis
2023 · Cell & Bioscience · 3 citations
https://doi.org/10.1186/s13578-023-01023-5
Suppression of type I interferon production by human T-cell leukemia virus type 1 oncoprotein Tax
2014 · Retrovirology · 1 citations
https://doi.org/10.1186/1742-4690-11-s1-p77
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat